Subscribe
VBCR - April 2014, Volume 3, No 2 - Personalized Medicine in Rheumatology
Alice Goodman

A previously unknown locus for rheumatoid arthritis (RA) susceptibility has been identified by researchers from the United Kingdom involved in the genome-wide association studies (GWAS), according to a recent study (Orozco G, et al. Arthritis Rheum. 2014;66:24-30). The new locus (rs1043099), located on chromosome 22q12 was found in an expanded cohort of UK patients; 32 RA loci have already been identified. These 30-plus gene regions account for <50% of the total genetic heritability of RA, said the investigators, but may eventually lead to therapeutic approaches.

“Increasing the number of known disease loci will facilitate the estimation of disease risk, potentially allow early intervention in high-risk groups, possibly informing prognosis, and, ultimately, aiding in the discovery of novel targets for pharmacologic therapy,” wrote senior investigator Stephen Eyre, PhD, Senior Research Fellow, Arthritis Research UK Epi­demi­ology Unit, University of Manchester, United Kingdom, and colleagues.

The expanded UK cohort of RA cases and controls added 1361 patients with RA and 2334 healthy controls to the existing UK GWAS base; in all, 3034 patients with RA and 5271 healthy controls were available for analysis. The additional cases and controls expand the power to identify novel RA risk loci in this UK population, the investigators stated.

The genotype data for RA cases and association testing of more than 1.8 million single-nucleotide polymorphisms (SNPs) were evaluated.

The results of the bioinformatics analyses showed that 6 novel RA loci previously associated with other autoimmune diseases, including type 1 diabetes and inflammatory bowel disease, have a suggestive association with susceptibility to RA (P <.001). Of these 6 associated loci, 2 were validated for association with RA. For rs1043099, validation significance reached. This locus exceeded genome-wide levels of significance in the combined analysis. There is also evidence in publicly functional annotation data suggesting that rs1043099 and its correlated SNPs may have regulatory activity in RA. The newly found SNP is located within a gene of unknown function, GATSL3.

“Using bioinformatics analysis, we showed that rs1043099 and its correlated SNPs have potential regulatory activity [in RA]….Further functional studies will be required to determine which of the SNPs is causal and to elucidate the mechanisms of action of each SNP,” stated Dr Eyre and colleagues.

The findings reported herein support the view that extending the size, and thus the power, of RA GWAS can lead to the discovery of new genes implicated in the development of the disease. There is hope that this accumulation of knowledge will have clinical importance in the future.

Related Items
Working in Cold Environment Increases Risk for RA
Alice Goodman
VBCR - April 2018, Vol 7, No 1 published on April 17, 2018 in Rheumatoid Arthritis
Stem-Cell Transplant Improves Survival in Patients with Severe Scleroderma
Alice Goodman
VBCR - April 2018, Vol 7, No 1 published on April 17, 2018 in Scleroderma
Treatment with Methotrexate Alone Yields Similar Outcomes to Combination Therapy in Early RA
Alice Goodman
VBCR - April 2018, Vol 7, No 1 published on April 17, 2018 in Rheumatoid Arthritis
Adalimumab Biosimilar Shown to Be Safe and Effective in Patients with RA
Alice Goodman
VBCR - April 2018, Vol 7, No 1 published on April 17, 2018 in Rheumatoid Arthritis
Early Treatment of Rheumatoid Arthritis Improves Functional Outcomes at 20 Years
Alice Goodman
VBCR - June 2017, Vol 6, No 2 published on June 29, 2017 in Rheumatoid Arthritis
Benefits of Tocilizumab Maintained for 2 Years in Patients with Early Rheumatoid Arthritis
Alice Goodman
VBCR - June 2017, Vol 6, No 2 published on June 29, 2017 in Rheumatoid Arthritis
New Electronic Health Record Algorithms Accurately Identify Patients with Systemic Lupus Erythematosus
Alice Goodman
VBCR - June 2017, Vol 6, No 2 published on June 29, 2017 in Lupus
Evidence-Based Recommendations Should Lead to Appropriate Use of Imaging for Osteoarthritis
Alice Goodman
VBCR - June 2017, Vol 6, No 2 published on June 29, 2017 in Osteoarthritis
Patients with Systemic Lupus Erythematosus Should Be Monitored for Electrocardiogram Abnormalities
Alice Goodman
VBCR - April 2017, Vol 6, No 1 published on May 3, 2017 in Lupus
Secukinumab Less Effective Than Abatacept in Patients with RA with No Response to TNF Inhibitors
Alice Goodman
VBCR - April 2017, Vol 6, No 1 published on May 3, 2017 in Rheumatology Center Profile
Last modified: May 21, 2015
  • Rheumatology Practice Management
  • Lynx CME
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology